Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialFlorence Ader, Raphaël Clère-Jehl, Maude Bouscambert‐Duchamp et al.|The Lancet Infectious Diseases|2021Cited by 344
High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory FailureLila Bouadma, Alexandra Grinea, Mehdi Marzouk et al.|JAMA Internal Medicine|2022Cited by 148
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trialsAlain Amstutz, Matthias Briel, Benjamin Speich et al.|The Lancet Respiratory Medicine|2023Cited by 124
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in FrancePaul Loubet, E. Dupeyrat, N. Lenzi et al.|Clinical Microbiology and Infection|2016Cited by 109
High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohortSarah Tubiana, Catherine Chirouze, Charles Burdet et al.|Journal of Infection|2021Cited by 7